The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) has awarded a $63,515,553.92 firm fixed price delivery order to Partner Therapeutics, Inc., a biopharmaceutical company based in Lexington, Massachusetts. The award is for the supply of LEUKINE 250MCG VIL INJ (5PKG), a drug used to treat neutropenia and other diseases. This delivery order is placed under Partner Therapeutics' existing Federal Supply Schedule contract with the Department of Veterans Affairs, which has a ceiling value of $4,413,920.00 and runs through August 2028. Partner Therapeutics is an experienced federal contractor, having previously received awards from ASPR and the Department of Defense to support medical countermeasures development and the supply of critical drugs and pharmaceuticals.
In addition to this ASPR delivery order, Partner Therapeutics holds several other indefinite delivery vehicle (IDV) contracts with the federal government. These include an Other Transaction Agreement with the Army for work related to chemical and biological defense projects, as well as a $9.7 million Other Transaction IDV awarded in 2022 to support PROJECT KICKOFF, likely involving early therapeutic agent development against chemical and biological threats. These IDVs allow for streamlined task order awards to Partner Therapeutics based on its core capabilities in targeted oncology, supportive care, and medical countermeasures.
Generated 11/23/24, 9:08 AM